Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Results from Gene ID Studies Could
Lead to New Dxs for Genomic Health

[June 11, 2008]

By Turna Ray

Studies presented at ASCO’s annual meeting could lead to the development of two new diagnostics tests, expanding the indication of Genomic Health’s Oncotype DX technology into gauging treatment benefit with Erbitux in colorectal cancer and Taxotere in breast cancer.

Login | Subscribe